Schrodinger

Overview

Schrödinger is a software company based in the United States, founded in 1990, specializing in engineering software and computational technologies. With a workforce of 501 to 1,000 employees, the company focuses on providing advanced solutions for structural biology and drug design. Their offerings include the Target Enablement Research Service, which aims to assist clients in preparing protein-ligand systems for structure-based design. This service leverages advancements in structural biology, including cryo-electron microscopy (cryo-EM) and machine learning technologies like AlphaFold, to refine protein structures and optimize ligand placement for accurate physics-based simulations. Schrödinger's expertise is particularly beneficial for projects where structural data is incomplete or evolving, helping teams accelerate their drug discovery programs by minimizing time spent on model preparation and validation. The company emphasizes its commitment to enhancing the efficiency of the drug development process through its sophisticated computational methods and knowledge in the field of structure-based drug design.

Industry